Document ID: chunk:federal_register_of_legislation:F2024L01547:schedule:1:p2
Version: federal_register_of_legislation:F2024L01547
Segment Type: schedule
Provision Reference: sch 1 (pt 2/3)
Character Range: 5702–9341

– entry for Ciprofloxacin
       Omit
Ciprofloxacin  Eye drops 3 mg (as hydrochloride) per mL, 5 mL  Application to the eye  Ciloxan  1  8.92  10.95

       Insert
Ciprofloxacin  Eye drops 3 mg (as hydrochloride) per mL, 5 mL  Application to the eye  Ciloxan  1  14.05  18.47

        1.                  Schedule 1 – after entry for Cyproterone
       Insert
Dabigatran etexilate  Capsule 110 mg (as mesilate)  Oral  Pradaxa  60  6.19   46.44
                      Capsule 150 mg (as mesilate)  Oral  Pradaxa  60  36.88  46.18

        1.                  Schedule 1 – entry for Diclofenac
       Omit
Diclofenac  Tablet (enteric coated) containing diclofenac sodium 25 mg  Oral  Voltaren 25  50  2.50  4.10
            Tablet (enteric coated) containing diclofenac sodium 50 mg  Oral  Voltaren 50  50  2.50  5.71

       Insert
Diclofenac  Tablet (enteric coated) containing diclofenac sodium 25 mg  Oral  Voltaren 25  50  2.50  4.83
            Tablet (enteric coated) containing diclofenac sodium 50 mg  Oral  Voltaren 50  50  2.50  7.31

        1.                  Schedule 1 – omit entry for Ezetimibe with atorvastatin
       Omit
Ezetimibe with atorvastatin  Tablet 10 mg‑10 mg  Oral  Atozet  30  6.97  8.97
                             Tablet 10 mg‑20 mg  Oral  Atozet  30  7.49  9.50
                             Tablet 10 mg‑40 mg  Oral  Atozet  30  8.33  10.40
                             Tablet 10 mg‑80 mg  Oral  Atozet  30  9.25  11.31

       Insert
Ezetimibe with atorvastatin  Tablet 10 mg‑20 mg  Oral  Atozet  30  7.49  9.50

        1.                  Schedule 1 – omit entry for Ketoprofen

        2.              Schedule 1 – entry for Letrozole
       Omit
Letrozole  Tablet 2.5 mg  Oral  Femara 2.5 mg  30  9.72  12.17

       Insert
Letrozole  Tablet 2.5 mg  Oral  Femara 2.5 mg  30  9.72  14.37

        1.              Schedule 1 – entry for Medroxyprogesterone
       Omit
Medroxyprogesterone  Injection containing medroxyprogesterone acetate 150 mg in 1 mL  Injection  Depo‑Provera  1   13.14  19.65
                     Tablet containing medroxyprogesterone acetate 5 mg               Oral       Provera       56  5.10   9.36
                     Tablet containing medroxyprogesterone acetate 10 mg              Oral       Provera       30  6.39   12.62

       Insert
Medroxyprogesterone  Tablet containing medroxyprogesterone acetate 5 mg   Oral  Provera  56  5.10  9.36
                     Tablet containing medroxyprogesterone acetate 10 mg  Oral  Provera  30  6.39  12.62

        1.              Schedule 1 – after entry for Metronidazole
       Insert
Minocycline  Tablet 50 mg (as hydrochloride)  Oral  Minomycin-50  60  8.51  11.51

        1.              Schedule 1 – after entry for Perindopril with indapamide
       Insert
Pramipexole  Tablet containing pramipexole dihydrochloride monohydrate 125 micrograms  Oral  Sifrol  30   3.04   6.54
             Tablet containing pramipexole dihydrochloride monohydrate 250 micrograms  Oral  Sifrol  100  13.75  17.25

        1.              Schedule 1 – entry for Pregabalin
       Omit
Pregabalin  Capsule 75 mg   Oral  Lyrica  56  4.68  9.20
            Capsule 150 mg  Oral  Lyrica  56  7.19  12.72

       Insert
Pregabalin  Capsule 25 mg   Oral  Lyrica  56  3.73   5.71
            Capsule 75 mg   Oral  Lyrica  56  4.68   9.20
            Capsule 150 mg  Oral  Lyrica  56  7.19   12.72
            Capsule 300 mg  Oral  Lyrica  56  10.72  12.58

        1.              Schedule 1 – entry for Telmisartan
       Omit
Telmisartan  Tablet 40 mg  Oral  Micardis  28  2.50  7.71
             Tablet 80 mg  Oral  Micardis